AXE COMPUTE INC (AGPU)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
QuarterlyIQ Insights · AGPU
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Other Events. On August 17, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has entered into agreements with Duos Technologies Group, Inc. for 55 MW of new AI data center capacity across multiple U.S. locations, representing over $500 million in expected aggregate payments. Additionally, the Company and Duos Technologies have executed nonbinding term sheets for minority equity investments by the Company in the entities associated with the projects, wi…
Results of Operations and Financial Condition. On August 14, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing its financial results for the quarterly period ended June 30, 2026. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.1) is deemed to be “furnished” and shall not be deemed to b…
Other Events. On July 27, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured a new five-year customer agreement with total contract value of over $1.5 billion to deploy a dedicated AI infrastructure cluster in the United States through the Axe Compute Build program. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 8.01, in…
Other Events. On July 22, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing that the Company has secured more than $1.3 billion in new customer contracts across the United States and Europe through the Axe Compute Build program. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information set forth in this Item 8.01, including Exhibit 99.1, is being “filed” for purposes of Section 18…
Results of Operations and Financial Condition. On May 15, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing its financial results for the quarterly period ended March 31, 2025. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.1) is deemed to be “furnished” and shall not be deemed to be…
Other Events. On May 15, 2026, Axe Compute Inc., a Delaware corporation, (the “Company”), filed a prospectus supplement (the “Prospectus Supplement) to the prospectus, dated May 21, 2024, filed with the Securities and Exchange Commission as part of its registration statement on Form S-3 (333-279123) (the “Registration Statement”), as supplemented by its prospectus supplement, dated May 21, 2024, as further supplemented by the prospectus supplements dated April 18, 2025 and October 29, 2025, a…
Chief Financial Officer — Josh Blacher: Josh Blacher resigned as Chief Financial Officer, and Jeremy Yaukey-Witter was appointed as the new CFO.
Other Events. On April 1, 2026, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding expected income trajectory, business model performance, and market opportunity. These statements involve known and unknown risks and uncertaintie…
President — Kyle Okamoto: Kyle Okamoto was appointed as President of the Company.
Results of Operations and Financial Condition. On March 31, 2026, Axe Compute Inc. (the “Company”) issued a press release announcing its financial results for the year ended December 31, 2025. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.1) is deemed to be “furnished” and shall not be deemed to be “filed”…
Director — Dr. Theodore Zhu and Mr. Thorston Dirks: Appointment of Dr. Theodore Zhu and Mr. Thorston Dirks to the Board of Directors.
CEO — Raymond F. Vennare: The CEO was terminated without cause and resigned from the board.
Director/Chief Investment Officer — Shawn Matthews, Veena Rao, Thomas McLaughlin: Multiple directors and a senior officer resigned from the company.
Chief Executive Officer — Raymond F. Vennare: Compensation and equity arrangements were amended for the CEO.
The filing is about an amendment to the equity incentive plan, not a management change.
Results of Operations and Financial Condition. On November 14, 2025, Predictive Oncology Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025 and provided an update on its digital asset strategy. The Company is furnishing a copy of the press release, which is attached hereto as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information set forth in this Current Report on Form 8-K (including Exhibit 99.…
Other Events. On October 29, 2025, Predictive Oncology Inc., a Delaware corporation, (the “Company”), filed a prospectus supplement (the “Prospectus Supplement) to the prospectus, dated May 21, 2024, filed with the Securities and Exchange Commission as part of its registration statement on Form S-3 (333-279123) (the “Registration Statement”), as supplemented by its prospectus supplement, dated May 21, 2024, as further supplemented by the prospectus supplements dated April 18, 2025 and June 2,…
Director — Nancy Chung-Welch, Ph.D.: Nancy Chung-Welch resigned from the Board of Directors and was succeeded by Shawn Matthews.
Unregistered Sales of Equity Securities. The information contained in
Other Information. Upon the anticipated closing of the Private Placements on or about October 2, 2025 and the transactions contemplated thereby, the predominant business activity of the Company will be the Company’s digital asset treasury strategy, which is focused on the ATH token. Aethir is a leading decentralized physical infrastructure network developed by DCI that provides a decentralized graphics processing unit (“ GPU ”) network, which connects producers and consumers of GPU compute po…
Entry Into a Material Definitive Agreement. Private Placement (Cash Offering) Cash Securities Purchase Agreement On September 29, 2025, Predictive Oncology Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Cash Securities Purchase Agreement ”) with certain accredited investors (the “ Cash Purchasers ”) pursuant to which the Company agreed to sell and issue to the Cash Purchasers in a private placement (the “ Cash Offering ”) an aggregate of (i…
Material Modification to Rights of Security Holders The information set forth under
The filing describes a compensatory arrangement involving RSU grants to executives, not a management change.
Entry into a Material Agreement. On August 26, 2025, Predictive Oncology Inc., a Delaware corporation (“ Predictive Oncology ” or the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with an accredited investor (the “ Investor ”) for the sale by the Company of 543,544 shares (the “ Shares ”) of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”) at a purchase price of $0.76 per Share in a private placement. The offering closed on…
In the Purchase Agreement, the Investor represented to the Company, among other things, that it is an “accredited investor” (as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”)). The issuance of the Shares pursuant to the Purchase Agreement has been issued and sold by the Company to the Investor in reliance upon the exemptions from the registration requirements of the Securities Act afforded by Section 4(a)(2) of the Se…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.